Showing results (51-60 of 104) with videos related to
Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|May 1, 1989
Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in childrenW E Evans, M V Relling, W P Petros, et al.Clinical Pharmacology and Therapeutics|October 1, 1993
Pharmacokinetics and acute renal effects of continuously infused carboplatinD J Murry, J T Sandlund, L M Stricklin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1990
Measurement of skin-to-kidney distance in children: implications for quantitative renographyD C Maneval, H L Magill, A M Cypess, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicityC F Stewart, S D Baker, R L Heideman, et al.Journal of Pharmaceutical Sciences|November 1, 1981
Pharmacokinetics of sustained serum methotrexate concentrations secondary to gastrointestinal obstructionW E Evans, A Tsiatis, W R Crom, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumorsS D Baker, R L Heideman, W R Crom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Escalating teniposide systemic exposure to increase dose intensity for pediatric cancer patientsJ H Rodman, W L Furman, M Sunderland, et al.Clinical Pharmacology and Therapeutics|June 1, 1987
Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapyM V Relling, W R Crom, J A Pieper, et al.Cancer Research|March 1, 1984
Teniposide (VM26) disposition in children with leukemiaJ A Sinkule, C F Stewart, W R Crom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
Etoposide pharmacokinetics in patients with normal and abnormal organ functionS G Arbuck, H O Douglass, W R Crom, et al.Pageof 11